nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—CHRM2—Propantheline—pancreatitis	0.483	0.529	CbGbCtD
Gallamine Triethiodide—CHRM2—Hyoscyamine—pancreatitis	0.43	0.471	CbGbCtD
Gallamine Triethiodide—Salivation—Propantheline—pancreatitis	0.0141	0.209	CcSEcCtD
Gallamine Triethiodide—Heart rate irregular—Hyoscyamine—pancreatitis	0.0104	0.154	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Propantheline—pancreatitis	0.00531	0.0785	CcSEcCtD
Gallamine Triethiodide—Blood disorder—Hyoscyamine—pancreatitis	0.00335	0.0496	CcSEcCtD
Gallamine Triethiodide—Swelling—Hyoscyamine—pancreatitis	0.0023	0.0341	CcSEcCtD
Gallamine Triethiodide—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—pancreatitis	0.00212	0.107	CbGpPWpGaD
Gallamine Triethiodide—Confusional state—Propantheline—pancreatitis	0.00197	0.0291	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Propantheline—pancreatitis	0.00191	0.0282	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Propantheline—pancreatitis	0.00161	0.0238	CcSEcCtD
Gallamine Triethiodide—Urticaria—Propantheline—pancreatitis	0.00155	0.0229	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Propantheline—pancreatitis	0.00144	0.0213	CcSEcCtD
Gallamine Triethiodide—Asthenia—Propantheline—pancreatitis	0.0014	0.0207	CcSEcCtD
Gallamine Triethiodide—Vomiting—Propantheline—pancreatitis	0.00124	0.0183	CcSEcCtD
Gallamine Triethiodide—Rash—Propantheline—pancreatitis	0.00123	0.0182	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Propantheline—pancreatitis	0.00123	0.0182	CcSEcCtD
Gallamine Triethiodide—Headache—Propantheline—pancreatitis	0.00122	0.0181	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Hyoscyamine—pancreatitis	0.0012	0.0177	CcSEcCtD
Gallamine Triethiodide—Nausea—Propantheline—pancreatitis	0.00116	0.0171	CcSEcCtD
Gallamine Triethiodide—Angioedema—Hyoscyamine—pancreatitis	0.00112	0.0165	CcSEcCtD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—DUSP10—pancreatitis	0.00108	0.0545	CbGpPWpGaD
Gallamine Triethiodide—Chest pain—Hyoscyamine—pancreatitis	0.00104	0.0154	CcSEcCtD
Gallamine Triethiodide—Confusional state—Hyoscyamine—pancreatitis	0.00101	0.0149	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Hyoscyamine—pancreatitis	0.000975	0.0144	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—GCG—pancreatitis	0.00088	0.0445	CbGpPWpGaD
Gallamine Triethiodide—Fatigue—Hyoscyamine—pancreatitis	0.000862	0.0127	CcSEcCtD
Gallamine Triethiodide—Pain—Hyoscyamine—pancreatitis	0.000855	0.0126	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Hyoscyamine—pancreatitis	0.000824	0.0122	CcSEcCtD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—CPB1—pancreatitis	0.000805	0.0407	CbGpPWpGaD
Gallamine Triethiodide—Urticaria—Hyoscyamine—pancreatitis	0.000794	0.0117	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Hyoscyamine—pancreatitis	0.00079	0.0117	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Hyoscyamine—pancreatitis	0.00079	0.0117	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Hyoscyamine—pancreatitis	0.000736	0.0109	CcSEcCtD
Gallamine Triethiodide—Asthenia—Hyoscyamine—pancreatitis	0.000717	0.0106	CcSEcCtD
Gallamine Triethiodide—Pruritus—Hyoscyamine—pancreatitis	0.000707	0.0105	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Hyoscyamine—pancreatitis	0.000684	0.0101	CcSEcCtD
Gallamine Triethiodide—Vomiting—Hyoscyamine—pancreatitis	0.000635	0.00939	CcSEcCtD
Gallamine Triethiodide—Rash—Hyoscyamine—pancreatitis	0.00063	0.00931	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Hyoscyamine—pancreatitis	0.00063	0.00931	CcSEcCtD
Gallamine Triethiodide—Headache—Hyoscyamine—pancreatitis	0.000626	0.00925	CcSEcCtD
Gallamine Triethiodide—Nausea—Hyoscyamine—pancreatitis	0.000594	0.00877	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—pancreatitis	0.000579	0.0293	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—DUSP1—pancreatitis	0.000532	0.0269	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—INS—pancreatitis	0.000495	0.025	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Glycerophospholipid biosynthesis—PLA2G1B—pancreatitis	0.000353	0.0178	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CASP12—pancreatitis	0.000319	0.0161	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—ALDH2—pancreatitis	0.000261	0.0132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—HTR2A—pancreatitis	0.000249	0.0126	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PLA2G1B—pancreatitis	0.000246	0.0124	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—GCG—pancreatitis	0.000243	0.0123	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—IL1B—pancreatitis	0.000222	0.0112	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—HTR2A—pancreatitis	0.000209	0.0106	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—HSP90AB1—pancreatitis	0.000201	0.0102	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—ALDH2—pancreatitis	0.0002	0.0101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—SMO—pancreatitis	0.000192	0.00968	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—INS—pancreatitis	0.000183	0.00923	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CNR1—pancreatitis	0.000162	0.00817	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—ALDH2—pancreatitis	0.000162	0.00817	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—TNF—pancreatitis	0.000161	0.00816	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—LEP—pancreatitis	0.00016	0.00807	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.000156	0.00788	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CPB1—pancreatitis	0.000152	0.00768	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—PPY—pancreatitis	0.000147	0.00742	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TACR1—pancreatitis	0.000146	0.0074	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000143	0.00724	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—CXCL8—pancreatitis	0.000142	0.00718	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—INS—pancreatitis	0.000136	0.0069	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL13—pancreatitis	0.00013	0.00655	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—KLK1—pancreatitis	0.000129	0.00653	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—ALDH2—pancreatitis	0.000124	0.00626	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—pancreatitis	0.000123	0.00622	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	0.000123	0.00622	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000119	0.006	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	0.000117	0.0059	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—SST—pancreatitis	0.000114	0.00575	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CASR—pancreatitis	0.000113	0.00573	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000112	0.00567	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—BDKRB2—pancreatitis	0.000111	0.00561	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—HTR2A—pancreatitis	0.000111	0.00559	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—MTNR1B—pancreatitis	0.000108	0.00547	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CNR2—pancreatitis	0.000106	0.00533	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.0001	0.00508	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—CD14—pancreatitis	9.9e-05	0.005	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—EGR1—pancreatitis	9.83e-05	0.00497	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	9.79e-05	0.00495	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	9.63e-05	0.00487	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PDGFA—pancreatitis	9.29e-05	0.0047	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—MDM2—pancreatitis	9.26e-05	0.00468	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PPY—pancreatitis	8.89e-05	0.00449	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	8.85e-05	0.00447	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	8.61e-05	0.00435	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	8.61e-05	0.00435	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	8.39e-05	0.00424	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	8.39e-05	0.00424	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	8.25e-05	0.00417	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—SST—pancreatitis	8.21e-05	0.00415	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL10—pancreatitis	8.11e-05	0.0041	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—pancreatitis	7.99e-05	0.00404	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	7.93e-05	0.00401	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—BDKRB2—pancreatitis	7.71e-05	0.0039	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—A2M—pancreatitis	7.66e-05	0.00387	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CNR1—pancreatitis	7.57e-05	0.00383	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CTRB2—pancreatitis	7.36e-05	0.00372	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—HTR2A—pancreatitis	7.18e-05	0.00363	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	7.16e-05	0.00362	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—MDM2—pancreatitis	7.09e-05	0.00358	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	7.03e-05	0.00355	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—KNG1—pancreatitis	7.02e-05	0.00355	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SCT—pancreatitis	6.87e-05	0.00347	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CASR—pancreatitis	6.87e-05	0.00347	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatitis	6.76e-05	0.00341	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CX3CL1—pancreatitis	6.74e-05	0.00341	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—MTNR1B—pancreatitis	6.56e-05	0.00331	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCK—pancreatitis	6.56e-05	0.00331	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	6.52e-05	0.0033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR2—pancreatitis	6.39e-05	0.00323	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—TACR1—pancreatitis	6.39e-05	0.00323	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FDX1—pancreatitis	6.39e-05	0.00323	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCKAR—pancreatitis	6.28e-05	0.00318	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	6.13e-05	0.0031	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	6.02e-05	0.00304	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	5.94e-05	0.003	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADH4—pancreatitis	5.94e-05	0.003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCL5—pancreatitis	5.87e-05	0.00297	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	5.73e-05	0.00289	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—MDM2—pancreatitis	5.73e-05	0.00289	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRSS1—pancreatitis	5.58e-05	0.00282	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	5.58e-05	0.00282	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PTHLH—pancreatitis	5.43e-05	0.00274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SMO—pancreatitis	5.43e-05	0.00274	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	5.32e-05	0.00269	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PNLIP—pancreatitis	5.29e-05	0.00267	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRSS3—pancreatitis	5.29e-05	0.00267	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—HRAS—pancreatitis	5.08e-05	0.00257	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PPY—pancreatitis	5.03e-05	0.00254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SST—pancreatitis	4.97e-05	0.00251	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	4.8e-05	0.00243	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—XDH—pancreatitis	4.75e-05	0.0024	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—BDKRB2—pancreatitis	4.67e-05	0.00236	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	4.67e-05	0.00236	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GCG—pancreatitis	4.59e-05	0.00232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR1—pancreatitis	4.58e-05	0.00232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPY—pancreatitis	4.56e-05	0.00231	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CXCL8—pancreatitis	4.44e-05	0.00224	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GCG—pancreatitis	4.43e-05	0.00224	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADH1B—pancreatitis	4.43e-05	0.00224	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—MDM2—pancreatitis	4.39e-05	0.00222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—pancreatitis	4.26e-05	0.00215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—KNG1—pancreatitis	4.25e-05	0.00215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—pancreatitis	4.25e-05	0.00215	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPL—pancreatitis	4.16e-05	0.0021	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	4.14e-05	0.00209	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	4.11e-05	0.00208	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—HRAS—pancreatitis	3.89e-05	0.00197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SCT—pancreatitis	3.88e-05	0.00196	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CASR—pancreatitis	3.88e-05	0.00196	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	3.87e-05	0.00195	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	3.84e-05	0.00194	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCK—pancreatitis	3.7e-05	0.00187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—MTNR1B—pancreatitis	3.7e-05	0.00187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatitis	3.69e-05	0.00187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR2—pancreatitis	3.61e-05	0.00182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—TACR1—pancreatitis	3.61e-05	0.00182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL5—pancreatitis	3.55e-05	0.0018	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCKAR—pancreatitis	3.55e-05	0.00179	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G1B—pancreatitis	3.53e-05	0.00178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SCT—pancreatitis	3.53e-05	0.00178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CASR—pancreatitis	3.53e-05	0.00178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CX3CL1—pancreatitis	3.46e-05	0.00175	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—A2M—pancreatitis	3.41e-05	0.00172	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCK—pancreatitis	3.36e-05	0.0017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MTNR1B—pancreatitis	3.36e-05	0.0017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR2—pancreatitis	3.28e-05	0.00166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TACR1—pancreatitis	3.28e-05	0.00166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCKAR—pancreatitis	3.23e-05	0.00163	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	3.21e-05	0.00162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—pancreatitis	3.2e-05	0.00162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatitis	3.18e-05	0.00161	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—HRAS—pancreatitis	3.14e-05	0.00159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2A—pancreatitis	3.13e-05	0.00158	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALDH2—pancreatitis	3.12e-05	0.00158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatitis	3.09e-05	0.00156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTHLH—pancreatitis	3.07e-05	0.00155	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	3.04e-05	0.00154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—pancreatitis	3.02e-05	0.00152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PNLIP—pancreatitis	3.01e-05	0.00152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SST—pancreatitis	2.81e-05	0.00142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTHLH—pancreatitis	2.79e-05	0.00141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SMO—pancreatitis	2.79e-05	0.00141	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—pancreatitis	2.73e-05	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPY—pancreatitis	2.7e-05	0.00136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP3CA—pancreatitis	2.66e-05	0.00134	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—BDKRB2—pancreatitis	2.64e-05	0.00133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR1—pancreatitis	2.59e-05	0.00131	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—pancreatitis	2.58e-05	0.0013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SST—pancreatitis	2.55e-05	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	2.54e-05	0.00128	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—pancreatitis	2.53e-05	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GCG—pancreatitis	2.5e-05	0.00126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—pancreatitis	2.49e-05	0.00126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—pancreatitis	2.45e-05	0.00124	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—HRAS—pancreatitis	2.41e-05	0.00122	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—KNG1—pancreatitis	2.4e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—BDKRB2—pancreatitis	2.4e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	2.39e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCG—pancreatitis	2.36e-05	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR1—pancreatitis	2.35e-05	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GCG—pancreatitis	2.27e-05	0.00115	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KNG1—pancreatitis	2.18e-05	0.0011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGG—pancreatitis	2.08e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SCT—pancreatitis	2.08e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASR—pancreatitis	2.08e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CX3CL1—pancreatitis	2.04e-05	0.00103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCL5—pancreatitis	2.01e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—pancreatitis	2e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCK—pancreatitis	1.99e-05	0.001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTNR1B—pancreatitis	1.99e-05	0.001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—A2M—pancreatitis	1.94e-05	0.000979	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR2—pancreatitis	1.94e-05	0.000979	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TACR1—pancreatitis	1.94e-05	0.000979	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—pancreatitis	1.94e-05	0.000978	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCKAR—pancreatitis	1.91e-05	0.000963	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPL—pancreatitis	1.85e-05	0.000937	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL5—pancreatitis	1.82e-05	0.000921	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGA—pancreatitis	1.77e-05	0.000895	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2A—pancreatitis	1.77e-05	0.000895	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTHLH—pancreatitis	1.65e-05	0.000832	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SMO—pancreatitis	1.65e-05	0.000832	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGB—pancreatitis	1.61e-05	0.000814	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2A—pancreatitis	1.61e-05	0.000812	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP3CA—pancreatitis	1.57e-05	0.000794	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SST—pancreatitis	1.51e-05	0.000761	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DUSP6—pancreatitis	1.49e-05	0.000754	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BDKRB2—pancreatitis	1.42e-05	0.000716	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR1—pancreatitis	1.39e-05	0.000702	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—pancreatitis	1.35e-05	0.000684	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GCG—pancreatitis	1.34e-05	0.000678	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—pancreatitis	1.33e-05	0.000671	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KNG1—pancreatitis	1.29e-05	0.000651	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—pancreatitis	1.26e-05	0.000635	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—pancreatitis	1.22e-05	0.000615	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFA—pancreatitis	1.18e-05	0.000599	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—pancreatitis	1.09e-05	0.000553	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL5—pancreatitis	1.08e-05	0.000544	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—pancreatitis	1.07e-05	0.000538	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPL—pancreatitis	1.05e-05	0.000532	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SPP1—pancreatitis	9.98e-06	0.000504	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—pancreatitis	9.93e-06	0.000502	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2A—pancreatitis	9.5e-06	0.00048	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—pancreatitis	8.83e-06	0.000446	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NRAS—pancreatitis	7.97e-06	0.000403	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—pancreatitis	7.54e-06	0.000381	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—pancreatitis	7.42e-06	0.000375	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—pancreatitis	6.86e-06	0.000347	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MDM2—pancreatitis	6.28e-06	0.000317	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—pancreatitis	5.87e-06	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRAS—pancreatitis	5.83e-06	0.000295	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—pancreatitis	5.62e-06	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—pancreatitis	5.58e-06	0.000282	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRAS—pancreatitis	4.71e-06	0.000238	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—pancreatitis	4.37e-06	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—pancreatitis	4.05e-06	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRAS—pancreatitis	3.44e-06	0.000174	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—pancreatitis	3.3e-06	0.000167	CbGpPWpGaD
